🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Immune-mediated Thrombotic thrombocytopenic purpura (iTTP) is a rare, autoi...
Status
Recruiting
Location
University of Minnesota
Start Date
2025-05-01
Trial ID
NCT06831058
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
This study is an open label, single center, prospective, 26 weeks study wit...
Status
Recruiting
Location
Clinique Neuro-Outaouais
Start Date
2025-02-06
Trial ID
NCT06765161
Treatments Being Tested
Title: The Efficacy, Safety, and PK/PD of Efgartigimod Followed by Telitaci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06827587
This study plans to learn more about if the drug efgartigimod can be used i...
Status
Recruiting
Location
University of Colorado
Start Date
2025-03-06
Trial ID
NCT06860633
Treatments Being Tested
The study is a Randomized, Open-label, Parallel Group Study to Compare the ...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2017-10-11
Trial ID
NCT03334084
Treatments Being Tested
This study's purpose is to measure the treatment response from efgartigimod...
Status
Completed
Location
Neuromuscular Research Center
Start Date
2022-10-12
Trial ID
NCT05523167
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of ublituxima...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-07-30
Trial ID
NCT07673744
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and tolerabil...
Status
Completed
Location
Investigator site 6 - US0010032
Start Date
2021-04-26
Trial ID
NCT04818671
Treatments Being Tested
This study aims to assess the efficacy and safety of efgartigimod PH20 in a...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-14
Trial ID
NCT07760818
Treatments Being Tested